PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGene therapy kickstarts stem cells to help blind mice see

BioNews

Gene therapy kickstarts stem cells to help blind mice see

Published 17 August 2018 posted in News and appears in BioNews 963

Author

Dr Kimberley Bryon-Dodd

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Scientists have partially restored sight in mice with congenital blindness by using gene therapy to activate retinal stem cells...

Scientists have partially restored sight in mice with congenital blindness by using gene therapy to activate retinal stem cells.

Humans and mice have supportive cells at the back of the eye called Müller glia cells, which in some animals such as zebrafish act as stem cells - replacing damaged cells to restore sight. However, this is not the case in mammals. Previous studies have shown that Müller glia cells can proliferate in injured mammalian retinas but only a few turned into new retinal cells.

In the current study, researchers have managed to trigger the Müller glia cells into becoming one type of light receptor cell – rod photoreceptors – without needing to injure the animal's eye.

'The biggest takeaway from this paper is that it is possible to reprogramme Müller glia in mammalian retina and partially restore visual function,' said Dr Bo Chen, a lead study author at the Icahn School of Medicine at Mount Sinai in New York City, New York.

Rod photoreceptors help the eye to detect light at lower levels, and also help preserve a second set of photoreceptors in the retina called cones, which are important for colour vision.

The researchers used a two-step process to restore rod photoreceptors in the mice. First, they injected into the retinas of the mice a gene for beta-catenin to encourage the glia cells to divide. Then a second injection containing genes for transcription factors that then encouraged these newly-formed cells to turn into rod photoreceptors, was given.

The study also showed that as well as having a normal appearance, the newly-formed rod photoreceptors behaved similarly to naturally present ones, producing the same characteristic proteins. By using this technique in mice that were born blind the scientists were also able to show that the neurons responded to light and the cells were therefore functional.

To determine how much sight has been regained in these animals, the authors plan on conducting behavioural studies that depend on vision. They also hope to test their technique on human retinal tissue grown in the lab.

'This is an exciting paper, as many labs have been trying to reprogramme Müller glia in mammals for some time now,' Dr Anand Swaroop, a neurobiologist at the National Eye Insititute in Bethesda, Maryland, who was not involved in the study told The Scientist.

While the study may give hope to people with blindness, it is unknown whether the technique will work in humans and clinical trials are a long way off.

Helen Lee at the UK's Royal National Institute of Blind People in London, told The Times: 'Clearly it is still at a very early stage, but at some point in the future stem cell treatment may become part of the armoury of treatments for sight-threatening eye conditions.'

The study was published in Nature.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 May 2021 • 2 minutes read

Blind man regains partial vision after optogenetic therapy

by Jen Willows

A new type of gene therapy has helped a man regain some vision after 40 years...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 September 2019 • 2 minutes read

NHS to provide gene therapy for rare eye disease

by Jen Willows

An in-body gene therapy treatment has been approved to treat a rare genetic form of blindness...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
21 September 2018 • 2 minutes read

Skeletal stem cells discovered in humans

by Shaoni Bhattacharya

Scientists have found sources of skeletal stem cells in humans for the first time...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
8 June 2018 • 2 minutes read

FDA puts major CRISPR genome editing trial on hold

by Christie Whitehouse

The US drugs regulator has put on hold an application for a clinical trial of a new genome editing based treatment for sickle cell disease...

Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false colour).
CC BY 4.0
Image by Sílvia Ferreira, Cristina Lopo and Eileen Gentleman via the Wellcome Collection. Depicts a single human stem cell embedded within a porous hydrogel matrix (false-coloured cryogenic scanning electron micrograph).
News
6 April 2018 • 2 minutes read

Stem cell implant improves dry macular degeneration

by Dr Caroline Casey

A stem cell implant appears to be safe, suggest the results of a clinical trial for the dry form of age-related macular degeneration...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 January 2018 • 2 minutes read

Gene therapy temporarily halts type 1 diabetes in mice

by Isobel Steer

A gene therapy has been used to restore normal blood sugar levels in mice with type 1 diabetes, according to a study published this month in the journal Cell Stem Cell.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 October 2017 • 2 minutes read

Gene therapy restores vision in blind mice

by Dr Kimberley Bryon-Dodd

Gene therapy has restored some vision in mice blinded by retinitis pigmentosa, an inherited degenerative eye disease...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Elephants' 'zombie gene' may give cancer insights

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856